company background image
BHC logo

Bausch Health Companies NYSE:BHC Stock Report

Last Price

US$6.31

Market Cap

US$2.2b

7D

0.5%

1Y

-13.8%

Updated

12 Jun, 2024

Data

Company Financials +

Bausch Health Companies Inc.

NYSE:BHC Stock Report

Market Cap: US$2.2b

BHC Stock Overview

Operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally.

BHC fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Bausch Health Companies Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bausch Health Companies
Historical stock prices
Current Share PriceUS$6.31
52 Week HighUS$11.46
52 Week LowUS$6.09
Beta0.82
1 Month Change-11.50%
3 Month Change-30.58%
1 Year Change-13.80%
3 Year Change-78.90%
5 Year Change-72.42%
Change since IPO1,162.00%

Recent News & Updates

The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

May 21
The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

Why Bausch Health Stock Plunged After Posting First-Quarter 2024 Results

May 07

Recent updates

The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

May 21
The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

Why Bausch Health Stock Plunged After Posting First-Quarter 2024 Results

May 07

Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation

Feb 24

Bausch Health: $20bn Debt Is A Mighty Elephant In The Room

Nov 30

Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Nov 01
Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics

Sep 24

Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Jul 24
Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes

Jul 06

What To Do After Bausch Health Stock Plunged By Nearly 9% Again

Jun 07

Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Apr 18
Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Bausch Health: A Basket Case Of A Business Only A Hedge Fund Can Bail Out

Dec 30

Bausch Health acne lotion Arazlo available in Canada under public drug plans

Dec 22

Bausch Health: Things To Consider Before Investing

Dec 11

Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Nov 10
Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Bausch Health Companies Q3 2022 Earnings Preview

Nov 02

Bausch Health: Long-Term Need To Place Stops For Protection

Sep 28

Bausch Health Companies: Equity Stub Would Benefit From Ambitious Spinoff

Sep 21

Bausch Health sheds 10% as FDA grants tentative approval for Xifaxan generic

Sep 08

Bausch Health begin offers to exchange debt up to $4B

Aug 31

Bausch Health Stock Down 11%: Now What?

Aug 09

Shareholder Returns

BHCUS PharmaceuticalsUS Market
7D0.5%1.8%1.3%
1Y-13.8%18.5%21.0%

Return vs Industry: BHC underperformed the US Pharmaceuticals industry which returned 18.5% over the past year.

Return vs Market: BHC underperformed the US Market which returned 21% over the past year.

Price Volatility

Is BHC's price volatile compared to industry and market?
BHC volatility
BHC Average Weekly Movement5.8%
Pharmaceuticals Industry Average Movement9.8%
Market Average Movement5.8%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.8%

Stable Share Price: BHC's share price has been volatile over the past 3 months.

Volatility Over Time: BHC's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a20,270Tom Appiowww.bauschhealth.com

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

Bausch Health Companies Inc. Fundamentals Summary

How do Bausch Health Companies's earnings and revenue compare to its market cap?
BHC fundamental statistics
Market capUS$2.24b
Earnings (TTM)-US$455.00m
Revenue (TTM)US$8.97b

0.3x

P/S Ratio

-5.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BHC income statement (TTM)
RevenueUS$8.97b
Cost of RevenueUS$2.62b
Gross ProfitUS$6.35b
Other ExpensesUS$6.80b
Earnings-US$455.00m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.24
Gross Margin70.81%
Net Profit Margin-5.07%
Debt/Equity Ratio-12,686.2%

How did BHC perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.